CTOs on the Move

Harmac Medical Products

www.harmac.com

 
Harmac Medical Products, Inc is a Buffalo, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.harmac.com
  • 2201 Bailey Ave
    Buffalo, NY USA 14211
  • Phone: 716.897.4500

Executives

Name Title Contact Details

Similar Companies

Schick Technologies

Schick Technologies is a Long Island City, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

DXE Medical

DXE Medical is a Brentwood, TN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Shield Healthcare Centers

Shield Healthcare offers a dynamic work environment with competitive salaries and a comprehensive benefits package. Check out our careers section for exciting opportunities.

ResMed

ResMed (NYSE: RMD, ASX: RMD), a world-leading connected health company with more than 4 million cloud-connected devices for daily remote patient monitoring, changes lives with every breath. Its award-winning devices and software solutions help treat and manage sleep apnea, chronic obstructive pulmonary disease and other respiratory conditions. Its 6,000-member team strives to improve patients’ quality of life, reduce the impact of chronic disease and save healthcare costs in more than 120 countries.

Seno Medical Instruments

Seno Medical Instruments, Inc. is a San Antonio, Texas-based medical imaging company committed to the development and commercialization of a new modality in cancer diagnosis: opto-acoustic imaging. Seno`s Imagio breast imaging system fuses opto-acoustic technology with ultrasound to generate functional and anatomical images of the breast. The opto-acoustic images provide a unique blood map in and around suspicious breast masses while the ultrasound provides a traditional anatomic image. Through the appearance or absence of the two hallmark indicators of cancer – angiogenesis and deoxygenation – Seno believes that the Imagio OA breast imaging system will be a more effective tool to help radiologists confirm or rule out malignancy than current diagnostic imaging modalities – without exposing patients to potentially harmful ionizing radiation (x-rays) or contrast agents.